文献速递乳房整形与再造

乳房切除术后放疗后自体乳房再造时机分析

An Analysis of the Timing of Autologous Breast Reconstruction after Mastectomy and Radiotherapy.
PubMed 文献 · Plast Reconstr Surg · 2026-01-22

该回顾性研究分析了339例患者共514个皮瓣,按放疗与否及放疗后至自体乳房再造的时间间隔(0-3、3-6、6-12、>12个月)分层,发现放疗与否及不同时间间隔在皮瓣失败、坏死、再手术等并发症上均无统计学显著差异。

要点

  • 放疗后不同时间间隔(0-3至>12个月)行自体乳房再造,并发症无显著差异。
  • 放疗与否在再手术、皮瓣血栓、皮瓣失败、感染等结局上无显著差异。
  • 结果不支持放疗至再造间隔与并发症率存在强关联。

核心结论

  • 放疗后不同时间间隔行自体乳房再造,术后并发症无统计学显著差异。
  • 研究结果不支持放疗至自体乳房再造的间隔与并发症率存在强关联。

研究设计与样本

  • 回顾性分析成年女性自体乳房再造患者,按皮瓣分析。
  • 共纳入339例患者、514个皮瓣,其中37.2%的皮瓣在乳房切除术后放疗背景下完成。
  • 放疗组按放疗结束至再造时间分为0-3、3-6、6-12、>12个月四组。
  • 主要结局为皮瓣失败或坏死及即刻再手术,其余并发症为次要结局。
  • 采用卡方、Fisher精确、Kruskal-Wallis、Wilcoxon秩和检验及 logistic 混合效应模型分析。

主要发现

  • 放疗组皮瓣时间分布:0-3个月5个,3-6个月72个,6-12个月71个,>12个月43个。
  • 放疗与否在再手术、皮瓣血栓、皮瓣失败、感染、伤口裂开及手术时间上均无统计学显著差异。
  • 不同时间间隔组间上述结局亦无统计学显著差异。

临床怎么用

  • 临床可依据患者个体情况安排放疗后自体乳房再造时机,无需因担心并发症而强制延迟特定时长。
  • 需结合患者意愿、组织条件及医疗资源综合决策。

局限性

  • 回顾性研究设计。
  • 0-3个月组样本量仅5个皮瓣,样本量小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Autologous breast reconstruction (ABR) after postmastectomy radiotherapy (PMRT) is often delayed several months due to the adverse effects of radiation on outcomes. The optimal time between PMRT and ABR remains uncertain. The authors sought to analyze how the timing of ABR after PMRT affects postoperative outcomes. METHODS: A retrospective analysis was performed in adult female patients who underwent ABR. Cases were analyzed on a per-flap basis and were stratified into PMRT and non-PMRT groups. The PMRT group was further stratified into cohorts based on the time from completion of PMRT to ABR defined as follows: 0 to 3, 3 to 6, 6 to 12, and more than 12 months. Primary outcomes included flap failure or necrosis and immediate reoperation. All other complications were secondary outcomes. Group differences were assessed using chi-squared, Fisher exact, Kruskal-Wallis, and Wilcoxon rank sum tests. A logistic mixed-effects model was conducted to identify variables associated with postoperative complications. RESULTS: Among 339 patients, 514 flaps were included. A total of 37.2% of flaps were performed in the setting of PMRT: 5 within 0 to 3 months, 72 within 3 to 6 months, 71 within 6 to 12 months, and 43 within more than 12 months. There were no statistically significant differences in reoperations, flap thrombosis, flap failure, infection, wound dehiscence, or operative time when comparing cases with or without PMRT and no statistically significant differences when comparing cases at the various time intervals. CONCLUSIONS: No statistically significant differences in postoperative complications were observed across PMRT timing intervals. These findings do not support a strong association between the interval from radiotherapy to ABR and complication rates.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Dadzie AI, Rossman A, Hansen K, et al. An Analysis of the Timing of Autologous Breast Reconstruction after Mastectomy and Radiotherapy. Plast Reconstr Surg. 2026. PMID: 41568996. doi:10.1097/PRS.0000000000012841

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。